Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Sep 1;100(5):1209–1216. doi: 10.1172/JCI119634

Induction of heme oxygenase-1 inhibits the monocyte transmigration induced by mildly oxidized LDL.

K Ishikawa 1, M Navab 1, N Leitinger 1, A M Fogelman 1, A J Lusis 1
PMCID: PMC508298  PMID: 9276739

Abstract

Heme catabolic processes produce the antioxidants biliverdin and bilirubin, as well as the potent prooxidant free iron. Since these products have opposing effects on oxidative stress, it is not clear whether heme catabolism promotes or inhibits inflammatory processes, including atherosclerotic lesion formation. Heme oxygenase (HO) catalyzes the rate-limiting step of heme catabolism. We used cocultures of human aortic endothelial cells and smooth muscle cells to examine the possible role of HO in early atherosclerosis. Heme oxygenase-1 (HO-1), the inducible isoform of HO, was highly induced by mildly oxidized LDL, and augmented induction was observed with hemin pretreatment. This augmented HO-1 induction resulted in the reduction of monocyte chemotaxis in response to LDL oxidation. Conversely, inhibition of HO by a specific inhibitor, Sn-protoporphyrin IX, enhanced chemotaxis. Furthermore, pretreatment with biliverdin or bilirubin, the products of HO, reduced chemotaxis. Oxidized phospholipids in the mildly oxidized LDL appear to be responsible for HO-1 induction, since oxidized but not native arachidonic acid-containing phospholipids also induced HO-1. These results suggest that HO-1 induced by mildly oxidized LDL may protect against the induction of inflammatory responses in artery wall cells through the production of the antioxidants biliverdin and bilirubin.

Full Text

The Full Text of this article is available as a PDF (338.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abraham N. G., Lavrovsky Y., Schwartzman M. L., Stoltz R. A., Levere R. D., Gerritsen M. E., Shibahara S., Kappas A. Transfection of the human heme oxygenase gene into rabbit coronary microvessel endothelial cells: protective effect against heme and hemoglobin toxicity. Proc Natl Acad Sci U S A. 1995 Jul 18;92(15):6798–6802. doi: 10.1073/pnas.92.15.6798. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Agarwal A., Balla J., Balla G., Croatt A. J., Vercellotti G. M., Nath K. A. Renal tubular epithelial cells mimic endothelial cells upon exposure to oxidized LDL. Am J Physiol. 1996 Oct;271(4 Pt 2):F814–F823. doi: 10.1152/ajprenal.1996.271.4.F814. [DOI] [PubMed] [Google Scholar]
  3. Alam J., Cai J., Smith A. Isolation and characterization of the mouse heme oxygenase-1 gene. Distal 5' sequences are required for induction by heme or heavy metals. J Biol Chem. 1994 Jan 14;269(2):1001–1009. [PubMed] [Google Scholar]
  4. Alam J., Den Z. Distal AP-1 binding sites mediate basal level enhancement and TPA induction of the mouse heme oxygenase-1 gene. J Biol Chem. 1992 Oct 25;267(30):21894–21900. [PubMed] [Google Scholar]
  5. Balla G., Jacob H. S., Balla J., Rosenberg M., Nath K., Apple F., Eaton J. W., Vercellotti G. M. Ferritin: a cytoprotective antioxidant strategem of endothelium. J Biol Chem. 1992 Sep 5;267(25):18148–18153. [PubMed] [Google Scholar]
  6. Balla G., Vercellotti G. M., Muller-Eberhard U., Eaton J., Jacob H. S. Exposure of endothelial cells to free heme potentiates damage mediated by granulocytes and toxic oxygen species. Lab Invest. 1991 May;64(5):648–655. [PubMed] [Google Scholar]
  7. Balla J., Jacob H. S., Balla G., Nath K., Eaton J. W., Vercellotti G. M. Endothelial-cell heme uptake from heme proteins: induction of sensitization and desensitization to oxidant damage. Proc Natl Acad Sci U S A. 1993 Oct 15;90(20):9285–9289. doi: 10.1073/pnas.90.20.9285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Berliner J. A., Heinecke J. W. The role of oxidized lipoproteins in atherogenesis. Free Radic Biol Med. 1996;20(5):707–727. doi: 10.1016/0891-5849(95)02173-6. [DOI] [PubMed] [Google Scholar]
  9. Berliner J. A., Territo M. C., Sevanian A., Ramin S., Kim J. A., Bamshad B., Esterson M., Fogelman A. M. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J Clin Invest. 1990 Apr;85(4):1260–1266. doi: 10.1172/JCI114562. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cantoni L., Rossi C., Rizzardini M., Gadina M., Ghezzi P. Interleukin-1 and tumour necrosis factor induce hepatic haem oxygenase. Feedback regulation by glucocorticoids. Biochem J. 1991 Nov 1;279(Pt 3):891–894. doi: 10.1042/bj2790891. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Christodoulides N., Durante W., Kroll M. H., Schafer A. I. Vascular smooth muscle cell heme oxygenases generate guanylyl cyclase-stimulatory carbon monoxide. Circulation. 1995 May 1;91(9):2306–2309. doi: 10.1161/01.cir.91.9.2306. [DOI] [PubMed] [Google Scholar]
  12. Cruse I., Maines M. D. Evidence suggesting that the two forms of heme oxygenase are products of different genes. J Biol Chem. 1988 Mar 5;263(7):3348–3353. [PubMed] [Google Scholar]
  13. Cushing S. D., Berliner J. A., Valente A. J., Territo M. C., Navab M., Parhami F., Gerrity R., Schwartz C. J., Fogelman A. M. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc Natl Acad Sci U S A. 1990 Jul;87(13):5134–5138. doi: 10.1073/pnas.87.13.5134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Fakhrai H., Maines M. D. Expression and characterization of a cDNA for rat kidney biliverdin reductase. Evidence suggesting the liver and kidney enzymes are the same transcript product. J Biol Chem. 1992 Feb 25;267(6):4023–4029. [PubMed] [Google Scholar]
  15. Fogelman A. M., Elahi F., Sykes K., Van Lenten B. J., Territo M. C., Berliner J. A. Modification of the Recalde method for the isolation of human monocytes. J Lipid Res. 1988 Sep;29(9):1243–1247. [PubMed] [Google Scholar]
  16. Frei B., Stocker R., Ames B. N. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci U S A. 1988 Dec;85(24):9748–9752. doi: 10.1073/pnas.85.24.9748. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. HAVEL R. J., EDER H. A., BRAGDON J. H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955 Sep;34(9):1345–1353. doi: 10.1172/JCI103182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Hopkins P. N., Wu L. L., Hunt S. C., James B. C., Vincent G. M., Williams R. R. Higher serum bilirubin is associated with decreased risk for early familial coronary artery disease. Arterioscler Thromb Vasc Biol. 1996 Feb;16(2):250–255. doi: 10.1161/01.atv.16.2.250. [DOI] [PubMed] [Google Scholar]
  19. Hulea S. A., Wasowicz E., Kummerow F. A. Inhibition of metal-catalyzed oxidation of low-density lipoprotein by free and albumin-bound bilirubin. Biochim Biophys Acta. 1995 Oct 26;1259(1):29–38. doi: 10.1016/0005-2760(95)00125-v. [DOI] [PubMed] [Google Scholar]
  20. Inamdar N. M., Ahn Y. I., Alam J. The heme-responsive element of the mouse heme oxygenase-1 gene is an extended AP-1 binding site that resembles the recognition sequences for MAF and NF-E2 transcription factors. Biochem Biophys Res Commun. 1996 Apr 25;221(3):570–576. doi: 10.1006/bbrc.1996.0637. [DOI] [PubMed] [Google Scholar]
  21. Ishikawa K., Sato M., Yoshida T. Expression of rat heme oxygenase in Escherichia coli as a catalytically active, full-length form that binds to bacterial membranes. Eur J Biochem. 1991 Nov 15;202(1):161–165. doi: 10.1111/j.1432-1033.1991.tb16357.x. [DOI] [PubMed] [Google Scholar]
  22. Johnson R. A., Lavesa M., Askari B., Abraham N. G., Nasjletti A. A heme oxygenase product, presumably carbon monoxide, mediates a vasodepressor function in rats. Hypertension. 1995 Feb;25(2):166–169. doi: 10.1161/01.hyp.25.2.166. [DOI] [PubMed] [Google Scholar]
  23. Keyse S. M., Tyrrell R. M. Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite. Proc Natl Acad Sci U S A. 1989 Jan;86(1):99–103. doi: 10.1073/pnas.86.1.99. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Kutty R. K., Nagineni C. N., Kutty G., Hooks J. J., Chader G. J., Wiggert B. Increased expression of heme oxygenase-1 in human retinal pigment epithelial cells by transforming growth factor-beta. J Cell Physiol. 1994 May;159(2):371–378. doi: 10.1002/jcp.1041590221. [DOI] [PubMed] [Google Scholar]
  25. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  26. Lavrovsky Y., Schwartzman M. L., Levere R. D., Kappas A., Abraham N. G. Identification of binding sites for transcription factors NF-kappa B and AP-2 in the promoter region of the human heme oxygenase 1 gene. Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):5987–5991. doi: 10.1073/pnas.91.13.5987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Lee P. J., Alam J., Sylvester S. L., Inamdar N., Otterbein L., Choi A. M. Regulation of heme oxygenase-1 expression in vivo and in vitro in hyperoxic lung injury. Am J Respir Cell Mol Biol. 1996 Jun;14(6):556–568. doi: 10.1165/ajrcmb.14.6.8652184. [DOI] [PubMed] [Google Scholar]
  28. Lee P. J., Alam J., Wiegand G. W., Choi A. M. Overexpression of heme oxygenase-1 in human pulmonary epithelial cells results in cell growth arrest and increased resistance to hyperoxia. Proc Natl Acad Sci U S A. 1996 Sep 17;93(19):10393–10398. doi: 10.1073/pnas.93.19.10393. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Liao F., Andalibi A., deBeer F. C., Fogelman A. M., Lusis A. J. Genetic control of inflammatory gene induction and NF-kappa B-like transcription factor activation in response to an atherogenic diet in mice. J Clin Invest. 1993 Jun;91(6):2572–2579. doi: 10.1172/JCI116495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Maines M. D. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J. 1988 Jul;2(10):2557–2568. [PubMed] [Google Scholar]
  31. Morel D. W., DiCorleto P. E., Chisolm G. M. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis. 1984 Jul-Aug;4(4):357–364. doi: 10.1161/01.atv.4.4.357. [DOI] [PubMed] [Google Scholar]
  32. Morita T., Kourembanas S. Endothelial cell expression of vasoconstrictors and growth factors is regulated by smooth muscle cell-derived carbon monoxide. J Clin Invest. 1995 Dec;96(6):2676–2682. doi: 10.1172/JCI118334. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Morita T., Perrella M. A., Lee M. E., Kourembanas S. Smooth muscle cell-derived carbon monoxide is a regulator of vascular cGMP. Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1475–1479. doi: 10.1073/pnas.92.5.1475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Navab M., Hama S. Y., Van Lenten B. J., Drinkwater D. C., Laks H., Fogelman A. M. A new antiinflammatory compound, leumedin, inhibits modification of low density lipoprotein and the resulting monocyte transmigration into the subendothelial space of cocultures of human aortic wall cells. J Clin Invest. 1993 Mar;91(3):1225–1230. doi: 10.1172/JCI116284. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Navab M., Hough G. P., Stevenson L. W., Drinkwater D. C., Laks H., Fogelman A. M. Monocyte migration into the subendothelial space of a coculture of adult human aortic endothelial and smooth muscle cells. J Clin Invest. 1988 Dec;82(6):1853–1863. doi: 10.1172/JCI113802. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Navab M., Imes S. S., Hama S. Y., Hough G. P., Ross L. A., Bork R. W., Valente A. J., Berliner J. A., Drinkwater D. C., Laks H. Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J Clin Invest. 1991 Dec;88(6):2039–2046. doi: 10.1172/JCI115532. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Neuzil J., Stocker R. Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J Biol Chem. 1994 Jun 17;269(24):16712–16719. [PubMed] [Google Scholar]
  38. Noguchi M., Yoshida T., Kikuchi G. A stoichiometric study of heme degradation catalyzed by the reconstituted heme oxygenase system with special consideration of the production of hydrogen peroxide during the reaction. J Biochem. 1983 Apr;93(4):1027–1036. doi: 10.1093/oxfordjournals.jbchem.a134226. [DOI] [PubMed] [Google Scholar]
  39. Otterbein L., Sylvester S. L., Choi A. M. Hemoglobin provides protection against lethal endotoxemia in rats: the role of heme oxygenase-1. Am J Respir Cell Mol Biol. 1995 Nov;13(5):595–601. doi: 10.1165/ajrcmb.13.5.7576696. [DOI] [PubMed] [Google Scholar]
  40. Quinn M. T., Parthasarathy S., Fong L. G., Steinberg D. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci U S A. 1987 May;84(9):2995–2998. doi: 10.1073/pnas.84.9.2995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993 Apr 29;362(6423):801–809. doi: 10.1038/362801a0. [DOI] [PubMed] [Google Scholar]
  42. Sasahara M., Raines E. W., Chait A., Carew T. E., Steinberg D., Wahl P. W., Ross R. Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. I. Is the extent of atherosclerosis related to resistance of LDL to oxidation? J Clin Invest. 1994 Jul;94(1):155–164. doi: 10.1172/JCI117301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Schwertner H. A., Jackson W. G., Tolan G. Association of low serum concentration of bilirubin with increased risk of coronary artery disease. Clin Chem. 1994 Jan;40(1):18–23. [PubMed] [Google Scholar]
  44. Shibahara S., Müller R. M., Taguchi H. Transcriptional control of rat heme oxygenase by heat shock. J Biol Chem. 1987 Sep 25;262(27):12889–12892. [PubMed] [Google Scholar]
  45. Siow R. C., Ishii T., Sato H., Taketani S., Leake D. S., Sweiry J. H., Pearson J. D., Bannai S., Mann G. E. Induction of the antioxidant stress proteins heme oxygenase-1 and MSP23 by stress agents and oxidised LDL in cultured vascular smooth muscle cells. FEBS Lett. 1995 Jul 17;368(2):239–242. doi: 10.1016/0014-5793(95)00650-x. [DOI] [PubMed] [Google Scholar]
  46. Steinberg D., Parthasarathy S., Carew T. E., Khoo J. C., Witztum J. L. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989 Apr 6;320(14):915–924. doi: 10.1056/NEJM198904063201407. [DOI] [PubMed] [Google Scholar]
  47. Steinbrecher U. P., Parthasarathy S., Leake D. S., Witztum J. L., Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci U S A. 1984 Jun;81(12):3883–3887. doi: 10.1073/pnas.81.12.3883. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Stocker R., Yamamoto Y., McDonagh A. F., Glazer A. N., Ames B. N. Bilirubin is an antioxidant of possible physiological importance. Science. 1987 Feb 27;235(4792):1043–1046. doi: 10.1126/science.3029864. [DOI] [PubMed] [Google Scholar]
  49. Suematsu M., Kashiwagi S., Sano T., Goda N., Shinoda Y., Ishimura Y. Carbon monoxide as an endogenous modulator of hepatic vascular perfusion. Biochem Biophys Res Commun. 1994 Dec 15;205(2):1333–1337. doi: 10.1006/bbrc.1994.2811. [DOI] [PubMed] [Google Scholar]
  50. Taketani S., Kohno H., Yoshinaga T., Tokunaga R. The human 32-kDa stress protein induced by exposure to arsenite and cadmium ions is heme oxygenase. FEBS Lett. 1989 Mar 13;245(1-2):173–176. doi: 10.1016/0014-5793(89)80215-7. [DOI] [PubMed] [Google Scholar]
  51. Tenhunen R., Marver H. S., Schmid R. Microsomal heme oxygenase. Characterization of the enzyme. J Biol Chem. 1969 Dec 10;244(23):6388–6394. [PubMed] [Google Scholar]
  52. Tsukamoto Y., Kuwabara K., Hirota S., Ikeda J., Stern D., Yanagi H., Matsumoto M., Ogawa S., Kitamura Y. 150-kD oxygen-regulated protein is expressed in human atherosclerotic plaques and allows mononuclear phagocytes to withstand cellular stress on exposure to hypoxia and modified low density lipoprotein. J Clin Invest. 1996 Oct 15;98(8):1930–1941. doi: 10.1172/JCI118994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Verma A., Hirsch D. J., Glatt C. E., Ronnett G. V., Snyder S. H. Carbon monoxide: a putative neural messenger. Science. 1993 Jan 15;259(5093):381–384. doi: 10.1126/science.7678352. [DOI] [PubMed] [Google Scholar]
  54. Vogt B. A., Alam J., Croatt A. J., Vercellotti G. M., Nath K. A. Acquired resistance to acute oxidative stress. Possible role of heme oxygenase and ferritin. Lab Invest. 1995 Apr;72(4):474–483. [PubMed] [Google Scholar]
  55. Watson A. D., Berliner J. A., Hama S. Y., La Du B. N., Faull K. F., Fogelman A. M., Navab M. Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. J Clin Invest. 1995 Dec;96(6):2882–2891. doi: 10.1172/JCI118359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Watson A. D., Leitinger N., Navab M., Faull K. F., Hörkkö S., Witztum J. L., Palinski W., Schwenke D., Salomon R. G., Sha W. Structural identification by mass spectrometry of oxidized phospholipids in minimally oxidized low density lipoprotein that induce monocyte/endothelial interactions and evidence for their presence in vivo. J Biol Chem. 1997 May 23;272(21):13597–13607. doi: 10.1074/jbc.272.21.13597. [DOI] [PubMed] [Google Scholar]
  57. Watson A. D., Navab M., Hama S. Y., Sevanian A., Prescott S. M., Stafforini D. M., McIntyre T. M., Du B. N., Fogelman A. M., Berliner J. A. Effect of platelet activating factor-acetylhydrolase on the formation and action of minimally oxidized low density lipoprotein. J Clin Invest. 1995 Feb;95(2):774–782. doi: 10.1172/JCI117726. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Williams R. J., Motteram J. M., Sharp C. H., Gallagher P. J. Dietary vitamin E and the attenuation of early lesion development in modified Watanabe rabbits. Atherosclerosis. 1992 Jun;94(2-3):153–159. doi: 10.1016/0021-9150(92)90240-h. [DOI] [PubMed] [Google Scholar]
  59. Witztum J. L., Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest. 1991 Dec;88(6):1785–1792. doi: 10.1172/JCI115499. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Yoshida T., Biro P., Cohen T., Müller R. M., Shibahara S. Human heme oxygenase cDNA and induction of its mRNA by hemin. Eur J Biochem. 1988 Feb 1;171(3):457–461. doi: 10.1111/j.1432-1033.1988.tb13811.x. [DOI] [PubMed] [Google Scholar]
  61. Zakhary R., Gaine S. P., Dinerman J. L., Ruat M., Flavahan N. A., Snyder S. H. Heme oxygenase 2: endothelial and neuronal localization and role in endothelium-dependent relaxation. Proc Natl Acad Sci U S A. 1996 Jan 23;93(2):795–798. doi: 10.1073/pnas.93.2.795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  62. Zhu W., Roma P., Pirillo A., Pellegatta F., Catapano A. L. Human endothelial cells exposed to oxidized LDL express hsp70 only when proliferating. Arterioscler Thromb Vasc Biol. 1996 Sep;16(9):1104–1111. doi: 10.1161/01.atv.16.9.1104. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES